target audience: TECH BUYER Publication date: Feb 2023 - Document type: IDC Perspective - Doc Document number: # US50201823
Retail Pharmacies — Transforming the Clinical Trial Landscape and Fueling Clinical Research as a Care Option (CRAACO)
Content
List of Figures
Get More
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.
Related Links
Abstract
This IDC Perspective analyzes the increasing involvement of retail pharmacies in clinical trials, especially in the United States, and how this is gradually making clinical research as a care option (CRAACO) a reality. It analyzes the various strategies being implemented by the retail pharmacies and provides guidance to the tech buyer on partnering decisions.
"In the past two years, retail pharmacies in the United States have rapidly entered the clinical trial arena, offering increased access to a diverse patient population, building out real-world data offerings, partnering with decentralized clinical trial vendors, and strengthening their primary care offerings. The integration of clinical trials within the patient's care continuum is important to increase access and improve outcomes. The global adoption of this model needs to follow, and this will happen over time. The race has just begun, and we have a long way to go," says Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC Health Insights.